PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- European stocks rise as markets stabilise, dollar set for weekly loss
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- Caterpillar names Derrick York to lead Resource Industries
Pure Bioscience, Inc. (PURE) Reports Q3 EPS of $0.00
December 15, 2025 4:09 PM ESTPure Bioscience, Inc. (OTC: PURE) reported Q3 EPS of $0.00. Revenue for the quarter came in at $708 thousand.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
... More


